Alnylam Pharmaceuticals Europe

Alnylam Pharmaceuticals Europe is owned by Alnylam Pharmaceuticals.

Alnylam Pharmaceuticals is one of the...

• Forbes Global 2000 (#1818);
• Russell 3000.

Alnylam Pharmaceuticals is a company listed under the stock ticker ALNY (US).

Alnylam Pharmaceuticals has a direct presence in 2 countries.

View the org chart displaying its 2 main executives

Most searched biographies at Alnylam Pharmaceuticals Europe

• Antoine Barouky, Vice President, General Manager & International B...
• Arianna Greco, Senior Vice President and Head, Global Commercial L...

Popular executive movements at Alnylam Pharmaceuticals

• Marsha Fanucci, Director, has left the company  (posted on September 29 2023).

Create your alert
to follow the executive moves at Alnylam Pharmaceuticals Europe.

Alnylam Pharmaceuticals has 2,277 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Histogen has filed for bankruptcy protection  (posted on April 19 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Alnylam Pharmaceuticals Europe

Social media about Alnylam Pharmaceuticals Europe

• Alnylam Pharmaceuticals Europe on Wikipedia, Google News & Yahoo Finance
• Alnylam Pharmaceuticals Europe on LinkedIn, Twitter & YouTube

Contact by email its executives including Antoine Barouky

Call Alnylam Pharmaceuticals Europe at +41 41...

View the org chart

Register to receive your alert

Report an error